Abiopharma

News list

Zieselman Neil Craig 🟢 acquired 6.9K shares (1 derivative) of Solventum Corp (SOLV) Transaction Date: Aug 17, 2026 | Filing ID: 000006

Full text

News bot Aug. 18, 2026, 8:52 p.m.
🔍 Zieselman Neil Craig (Executive)

Company: Solventum Corp (SOLV)

Report Date: 2026-08-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 6,911
Detailed Transactions and Holdings:
- Acquired 6,911 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2036-08-17 | equity_swap_involved: 0 | shares_owned_after: 6,911.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.
- F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of August 17, 2027; August 17, 2028; and August 17, 2029, subject to continued service through the vesting date.